Federal Register / Vol. 61, No. 83 / Monday, April 29, 1996 / Rules and Regulations 18671

Commenters wishing the FAA to

acknowledge receipt of their comments

submitted in response to this notice

must submit a self-addressed, stamped

postcard on which the following

statement is made: ‘‘Comments to

Docket No. 96–CE–21–AD.’’ The

postcard will be date stamped and

returned to the commenter.

The regulations adopted herein will

not have substantial direct effects on the

States, on the relationship between the

national government and the States, or

on the distribution of power and

responsibilities among the various

levels of government. Therefore, in

accordance with Executive Order 12612,

it is determined that this final rule does

not have sufficient federalism

implications to warrant the preparation

of a Federalism Assessment.

The FAA has determined that this

regulation is an emergency regulation

and that must be issued immediately to

correct an unsafe condition in aircraft,

and is not a significant regulatory action

under Executive Order 12866. It has

been determined further that this action

involves an emergency regulation under

DOT Regulatory Policies and Procedures

(44 FR 11034, February 26, 1979). If it

is determined that this emergency

regulation otherwise would be

significant under DOT Regulatory

Policies and Procedures, a final

regulatory evaluation will be prepared

and placed in the Rules Docket

(otherwise, an evaluation is not

required). A copy of it, if filed, may be

obtained from the Rules Docket.

List of Subjects in 14 CFR Part 39

Air transportation, Aircraft, Aviation

safety, Incorporation by reference,

Safety.

Adoption of the Amendment

Accordingly, pursuant to the

authority delegated to me by the

Administrator, the Federal Aviation

Administration amends part 39 of the

Federal Aviation Regulations (14 CFR

part 39) as follows:

PART 39—AIRWORTHINESS

DIRECTIVES

1. The authority citation for part 39

continues to read as follows:

Authority: 49 U.S.C. 106(g), 40113, 44701.

§ 39.13 [Amended]

2. Section 39.13 is amended by

adding a new airworthiness directive

(AD) to read as follows:

96–09–05 Diamond Aircraft Industries:

Amendment 39– 9579 ; Docket No. 96–

CE–21–AD.

Applicability: Model DA 20–A1 airplanes

(serial numbers 10002 through 10110),

certificated in any category.

Note 1: This AD applies to each airplane

identified in the preceding applicability

provision, regardless of whether it has been

modified, altered, or repaired in the area

subject to the requirements of this AD. For

airplanes that have been modified, altered, or

repaired so that the performance of the

requirements of this AD is affected, the

owner/operator must request approval for an

alternative method of compliance in

accordance with paragraph (d) of this AD.

The request should include an assessment of

the effect of the modification, alteration, or

repair on the unsafe condition addressed by

this AD; and, if the unsafe condition has not

been eliminated, the request should include

specific proposed actions to address it.

Compliance: Required within the next 10

hours time-in-service (TIS), unless already

accomplished.

To prevent the aileron controls from

becoming blocked causing jamming between

the short aileron pushrod and the pushrod

fairing exit, which, if not detected and

corrected, could cause loss of control of the

airplane, accomplish the following:

(a) Visually inspect the aft wing cavities

(both wings) for any manufacturing debris or

foreign objects and remove any debris found

in accordance with the ACCOMPLISHMENT

INSTRUCTIONS: ‘‘-Inspection’’ section of

Diamond Alert Service Bulletin (SB) No.

DA20–57–02, Rev. 0, Date Issued: March 7,

1996.

(b) Modify the aileron pushrod fairings

(both wings) in accordance with the

ACCOMPLISHMENT INSTRUCTIONS: ‘‘-

Modification of Fairing’’ section of Diamond

Alert SB No. DA20–57–02, Rev. 0, Date

Issued: March 7, 1996.

(c) Special flight permits may be issued in

accordance with sections 21.197 and 21.199

of the Federal Aviation Regulations (14 CFR

21.197 and 21.199) to operate the airplane to

a location where the requirements of this AD

can be accomplished.

(d) An alternative method of compliance or

adjustment of the initial or repetitive

compliance times that provides an equivalent

level of safety may be approved by the

Manager, Chicago Aircraft Certification

Office (ACO), 2300 E. Devon, Des Plaines,

Illinois 60018. The request shall be

forwarded through an appropriate FAA

Maintenance Inspector, who may add

comments and then send it to the Manager,

Chicago ACO.

Note 2: Information concerning the

existence of approved alternative methods of

compliance with this AD, if any, may be

obtained from the Chicago Aircraft

Certification Office.

(e) The inspection and modification

required by this AD shall be done in

accordance with Diamond Aircraft Industries

Alert Service Bulletin No. DA20–57–02, Rev.

0, Date Issued: March 7, 1996. This

incorporation by reference was approved by

the Director of the Federal Register in

accordance with 5 U.S.C. 552(a) and 1 CFR

part 51. Copies may be obtained from

Diamond Aircraft Industries, Inc., 690

Crumlin Sideroad, Ontario, Canada N5V 1S2;

telephone (519) 457–4000; facsimile (519)

457–4037. Copies may be inspected at the

FAA, Central Region, Office of the Assistant

Chief Counsel, Room 1558, 601 E. 12th

Street, Kansas City, Missouri, or at the Office

of the Federal Register, 800 North Capitol

Street, NW., 7th Floor, suite 700,

Washington, DC.

(f) This amendment (39–9579) becomes

effective on May 17, 1996.

Issued in Kansas City, Missouri, on April

18, 1996.

Henry A. Armstrong,

Acting Manager, Small Airplane Directorate,

Aircraft Certification Service.

[FR Doc. 96–10306 Filed 4–26–96; 8:45 am]

BILLING CODE 4910–13–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Food and Drug Administration

21 CFR Parts 510 and 522

Animal Drugs, Feeds, and Related

Products; Change of Sponsor

AGENCY: Food and Drug Administration,

HHS.

ACTION: Final rule.

SUMMARY: The Food and Drug

Administration (FDA) is amending the

animal drug regulations to reflect a

change of sponsor for approved new

animal drug applications (NADA’s) from

Fisons plc, Pharmaceutical Division to

Alstoe, Ltd., Animal Health.

EFFECTIVE DATE: April 29, 1996.

FOR FURTHER INFORMATION CONTACT:

Thomas J. McKay, Center for Veterinary

Medicine (HFV–102), Food and Drug

Administration, 7500 Standish Pl.,

Rockville, MD 20855, 301–827–0213.

SUPPLEMENTARY INFORMATION: Fisons

plc, Pharmaceutical Division, 12 Derby

Rd., Loughborough, Leicestershire, LE11

OBB, England, has informed the agency

that it has transferred the ownership of,

and all rights and interests in, approved

NADA’s 99–667 (Iron Dextran Complex

Injection) and 110–399 (Gleptoferron

Injection) to Alstoe, Ltd., Animal

Health, 19 Foxhill, Whissendine,

Oakham, Rutland, U.K., because the

firm is no longer the sponsor of any

approved NADA’s. Accordingly, the

agency is amending the regulations in

21 CFR 510.600(c)(1) and (c)(2) and the
18672 Federal Register / Vol. 61, No. 83 / Monday, April 29, 1996 / Rules and Regulations

drug labeler codes in 21 CFR 522.1055

and 522.1182 to reflect those changes.

List of Subjects

21 CFR Part 510

Administrative practice and

procedure, Animal drugs, Labeling,

Reporting and recordkeeping

requirements.

21 CFR Part 522

Animal drugs.

Therefore, under the Federal Food,

Drug, and Cosmetic Act and under

authority delegated to the Commissioner

of Food and Drugs and redelegated to

the Center for Veterinary Medicine, 21

CFR parts 510 and 522 are amended as

follows:

PART 510—NEW ANIMAL DRUGS

1. The authority citation for 21 CFR

part 510 continues to read as follows:

Authority: Secs. 201, 301, 501, 502, 503,

512, 701, 721 of the Federal Food, Drug, and

Cosmetic Act (21 U.S.C. 321, 331, 351, 352,

353, 360b, 371, 379e).

2. Section 510.600 is amended in the

table in paragraph (c)(1) by removing

the entry for ‘‘Fisons, plc,

Pharmaceutical Division’’ and by

alphabetically adding a new entry for

‘‘Alstoe, Ltd., Animal Health’’, and in

the table in paragraph (c)(2) by

removing the entry for ‘‘012525’’ and by

numerically adding a new entry for

‘‘062408’’ to read as follows:

§ 510.600 Names, addresses, and drug

labeler codes of sponsors of approved

applications.

* * * * *

(c) * * *

(1) * * *

Firm name and address Drug labeler code

* * * * * * *

Alstoe, Ltd., Animal Health, 19 Foxhill, Whissendine, Oakham, Rutland,

U.K.

062408

* * * * * * *

(2) * * *

Drug labeler code Firm name and address

* * * * * * *

062408 ...................................................................................................... Alstoe, Ltd., Animal Health, 19 Foxhill, Whissendine, Oakham, Rutland,

U.K.

* * * * * * *

PART 522—IMPLANTATION OR

INJECTABLE DOSAGE FORM NEW

ANIMAL DRUGS

3. The authority citation for 21 CFR

part 522 continues to read as follows:

Authority: Sec. 512 of the Federal Food,

Drug, and Cosmetic Act (21 U.S.C. 360b).

§ 522.1055 [Amended]

4. Section 522.1055 Gleptoferron

injection is amended in paragraph (b) by

removing ‘‘012525’’ and adding in its

place ‘‘062408’’.

§ 522.1182 [Amended]

5. Section 522.1182 Iron dextran

complex injection is amended in

paragraph (a)(4)(i) by removing

‘‘012525’’ and adding in its place

‘‘062408’’.

Dated: April 15, 1996.

Robert C. Livingston,

Director, Office of New Animal Drug

Evaluation, Center for Veterinary Medicine.

[FR Doc. 96–10546 Filed 4–26–96; 8:45 am]

BILLING CODE 4160–01–F

DEPARTMENT OF HOUSING AND

URBAN DEVELOPMENT

24 CFR Part 570

[Docket No. FR–2905–C–03]

RIN 2506–AB24

Office of the Assistant Secretary for

Community Planning and

Development; Community

Development Block Grant Program;

Correction of Identified Deficiencies

and Updates; Technical Correction

AGENCY: Office of the Assistant

Secretary for Community Planning and

Development, HUD.

ACTION: Technical correction.

SUMMARY: On November 9, 1995 (60 FR

56892), HUD published in the Federal

Register a final rule that corrected

identified deficiencies in the

Community Development Block (CDBG)

program, implemented relevant portions

of the Cranston-Gonzalez National

Affordable Housing Act, amended the

CDBG conflict of interest provisions,

implemented statutory changes from the

Housing and community Development

Act of 1987 and the Appropriations Act

of 1989, and provided criteria for

performance reviews and timely

expenditure of funds under the CDBG

program. This document corrects minor

errors in that final rule.

EFFECTIVE DATE: December 11, 1995.

FOR FURTHER INFORMATION CONTACT:

Deirdre Maguire-Zinni, Director,

Entitlement Communities Division,

Room 7282, Department of Housing and

Urban Development, 451 Seventh Street

SW., Washington, DC 20410, telephone

number (202) 708–1577. (This telephone

number is not toll-free.) Hearing- or

speech-impaired persons may access

this number via TTY by calling the

Federal Information Relay Service at

(800) 877–8339.

SUPPLEMENTARY INFORMATION:

I. Corrections to November 9, 1995

Final Rule

On November 9, 1995 (60 FR 56812),

HUD published a final rule in the